Literature DB >> 20804757

Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment.

Sang-Min Kang1, Seung-Jae Won, Gun-Hee Lee, Yun-Sook Lim, Soon B Hwang.   

Abstract

Interferon (IFN) response rate in hepatitis C virus (HCV) patients has been varied with genotypes. In this study, we investigated the effects of HCV NS5A protein on IFN resistance and compared the genotypic differences of NS5A. We showed that IFN-α-, poly I:C-, and Sendai virus-induced ISRE transcriptional activities were inhibited by both genotype 1b and 2a NS5A protein. We demonstrated that not only genotype 1b but also genotype 2a NS5A exerted the similar extent of IFN-α-induced antiviral activity. We showed that NS5A derived from both genotype 1b and 2a showed no significant differential IFN responses as seen in HCV patients. These data imply that some other host factor may be involved in genotypic differences of IFN antagonism in HCV patients.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804757     DOI: 10.1016/j.febslet.2010.08.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.

Authors:  Kattareeya Kumthip; Pattranuch Chusri; Nikolaus Jilg; Lei Zhao; Dahlene N Fusco; Hong Zhao; Kaku Goto; Du Cheng; Esperance A Schaefer; Leiliang Zhang; Chansom Pantip; Satawat Thongsawat; Amornrat O'Brien; Lee F Peng; Niwat Maneekarn; Raymond T Chung; Wenyu Lin
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  New insights regarding HCV-NS5A structure/function and indication of genotypic differences.

Authors:  Lilian Ht Yamasaki; Helen A Arcuri; Ana Carolina G Jardim; Cintia Bittar; Isabel Maria Vg de Carvalho-Mello; Paula Rahal
Journal:  Virol J       Date:  2012-01-12       Impact factor: 4.099

3.  Interferon sensitivity-determining region of hepatitis C virus influences virus production and interferon signaling.

Authors:  Ryuichi Sugiyama; Asako Murayama; Sayuri Nitta; Norie Yamada; Megumi Tasaka-Fujita; Takahiro Masaki; Hussein Hassan Aly; Masaaki Shiina; Akihide Ryo; Koji Ishii; Takaji Wakita; Takanobu Kato
Journal:  Oncotarget       Date:  2017-12-21

Review 4.  The role of HCV proteins on treatment outcomes.

Authors:  Kattareeya Kumthip; Niwat Maneekarn
Journal:  Virol J       Date:  2015-12-15       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.